Advances In Cancer Vaccines
Royal Sonesta Hotel
5 Cambridge Parkway
Cambridge, MA

Schedule of Presentations:

Wednesday, August 13, 2008
07:30:00 Registration and Morning Coffee
08:25:00 Chairperson’s Remarks
08:35:00 Opportunities and Challenges for Cancer Vaccines OPENING KEYNOTE PRESENTATION
09:05:00 Vaccine, Immunotherapy and the Immunological Constant or Rejection FEATURED PRESENTATION Francesco M Marincola
09:35:00 Treating Prostate Cancer Using Androgen Receptor Epitope (ARE) DNA Vaccinination David Zarling
10:05:00 Networking Coffee Break
10:45:00 GVAX Immunotherapy for Prostate Cancer Kristen M.Hege. M.D.
11:15:00 Development of a Therapeutic Vaccine Against HPV-Induced Cancer Joerg Schneider
11:45:00 Development of Optimized Cryptic Peptides for Tumor Immunotherapy Kostas Kosmatopoulos
12:15:00 Lunch on Your Own
13:40:00 Chairperson’s Remarks
13:45:00 Antigens Recognized by Cytolytic and Helper T Cells with Vaccine Potential for Cancer Patients Dorothee Herlyn
14:15:00 Enhancing the Efficacy of Cancer Immunotherapeutics and Vaccines by Suppressing the Induction of Regulatory T Cells Kingston Mills
14:45:00 Technology Trends
15:15:00 Networking Refreshment Break
16:00:00 Immunotherapeutic Potency of Embryonic and Sperm-Expressed Antigens Arya Biragyn
16:30:00 Cancer Mucosa Antigens as Novel Immunological Targets for Tumor Therapy Adam E Snook
17:00:00 Specific Lytic Antibody Production Against Myeloma Cell Associated CD38 Antigen by the Modified Vaccination Technique Arpad Z. Barabas
17:30:00 Happy Hour in the Exhibit Hall
18:00:00 End of Day One
Thursday, August 14, 2008
07:30:00 Registration and Morning Coffee
08:30:00 Chairperson’s Remarks
08:35:00 Dendritic Cell Tumor Fusions from the Bench to the Bedside KEYNOTE PRESENTATION David Avigan
09:05:00 GRNVAC1, hTERT-LAMP Transfected Autologous Dendritic Cell Vaccine for Cancer Laurence Elias
09:35:00 HAAH as a Cancer Specific Antigen for ex vivo Maturation of Dendritic Cells Hossein A. Ghanbari
10:05:00 Coffee Break in the Exhibit Hall
10:45:00 The Adenylate Cyclase from B.pertussis: a Protein Antigen Delivery System for Tumor Immunotherapy Muriam Bouillette
11:15:00 Technology Trends
11:45:00 Overcoming Challenges in Manufacturing and Commercializing an HSP-based Autologous Cancer Immunotherapeutic Stephen Monks
12:15:00 Lunch on Your Own
13:40:00 Chairperson’s Remarks William M. Egan
13:50:00 A CBER Perspective on the Use of Novel Adjuvants in Vaccines: Challenges and Opportunities Plenary Keynote Presentation Norman Baylor
14:30:00 Unique Vaccine Adjuvant Efficacy of Toll-like Receptor 8 (TLR8) Agonists that Activate Human Antigen-Presenting Cells KEYNOTE PRESENTATION Ofer Levy
15:00:00 CpG TLR9 Agonists as Adjuvants for Prophylactic and Therapeutic Vaccines FEATURED PRESENTATION Heather Davis
15:30:00 Artificial Cells Derived from Biodegradable Materials that Boost the Immune Response Tarek Fahmy
16:00:00 Refreshment Break in the Exhibit Hall
16:45:00 From “Alchemy” to Agonists of the Innate Immune System - Features and Applications of the Next Generation Vaccine Adjutants
17:15:00 The Use of SCV-07, a Novel Immune-Stimulating Dipeptide, as an Enhancer for Vaccines Cynthia Tuthill
17:45:00 Nanoemulsion-Based Vaccines are Safe Adjuvants that Deliver Antigens to Mucosal Surfaces
18:00:00 End of Day Two – Novel Vaccines, Close of Advances in Cancer Vaccines
3D Tissue Models
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.